Processing your request

please wait...

Case Page


Case Status:    ONGOING    
On or around 06/15/2020 (Date of last review)

Filing Date: June 15, 2020

According to the Complaint, Co-Diagnostics, Inc. owns proprietary technology that enables it to do DNA testing for diagnostic purposes.

The Complaint alleges that Defendants made continual, knowing and willful misstatements about their main product, a COVID-19 diagnostic test, to pump up the price of Co-Diagnostics, Inc.'s stock while the officers and directors exercised low priced options and dumped their stock into the market, and that these fraudulent misstatements, and disregard for the basic scientific principles that make their falsity of their statements clear in retrospect, caused investors to lose millions of dollars.


Sector: Healthcare
Industry: Biotechnology & Drugs
Headquarters: United States


Ticker Symbol: CODX
Company Market: NASDAQ
Market Status: Public (Listed)

About the Company & Securities Data

"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.

In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
COURT: D. Utah
DOCKET #: 20-CV-00368
DATE FILED: 06/15/2020
CLASS PERIOD END: 05/15/2020
  1. Fasano Law Firm, PLLC
  2. Marcus Neiman Rashbaum & Pineiro LLP
  3. Smith Washburn, LLP
No Document Title Filing Date
—Reference Complaint Complaint Related Data is not available
—Related District Court Filings Data is not available